Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,800,376
-$340,486 QoQ
Shares Held
34,837
+39.3% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $62,344,672 across 9 Diagnostics & Research names. GRAL ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CDNA |
CareDx, Inc.
|
864,468 | $15,007,164 | |
| 2 | NTRA |
Natera, Inc.
|
69,767 | $13,952,702 | |
| 3 | DHR |
Danaher Corp /De/
|
68,743 | $13,033,672 | |
| 4 | MYGN |
Myriad Genetics Inc
|
2,088,492 | $9,398,214 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
|
356,359 | $5,666,108 | |
| 6 | GRAL |
GRAIL, Inc.
This page
|
34,837 | $1,800,376 | |
| 7 | GH |
Guardant Health, Inc.
|
17,357 | $1,603,266 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
14,944 | $959,703 |
All Filings in GRAL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,800,376 | 34,837 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,140,862 | 25,013 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,962,951 | 67,021 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $6,044,061 | 117,543 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,134,658 | 83,581 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,208,874 | 1,020,105 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $762,782 | 49,628 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||